(Total Views: 266)
Posted On: 08/13/2020 2:46:47 PM
Post# of 36567
Let's focus on this:
MIRAMAR, FL, July 27, 2020 - Generex Biotechnology Corporation (www.generex.com)
(OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) today announced that the
FDA has accepted their pre-IND briefing package for the Ii-Key-SARS-CoV-2 coronavirus
prophylactic vaccine, and will provide a written response by August 24, 2020.
We need this and promising test results for Covid-19. Those two things happen, I suspect we'll be good. We don't have to be first or second but we need to finish the race.
MIRAMAR, FL, July 27, 2020 - Generex Biotechnology Corporation (www.generex.com)
(OTCQB:GNBT) (http://www.otcmarkets.com/stock/GNBT/quote) today announced that the
FDA has accepted their pre-IND briefing package for the Ii-Key-SARS-CoV-2 coronavirus
prophylactic vaccine, and will provide a written response by August 24, 2020.
We need this and promising test results for Covid-19. Those two things happen, I suspect we'll be good. We don't have to be first or second but we need to finish the race.
(4)
(0)
